Chemed (CHE) vs U.S. Physical Therapy (USPH)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
U.S. Physical Therapy (USPH) has outperformed Chemed (CHE) over the past year, gaining 33.9% versus a gain of 24.2%. Over five years, CHE leads with a +13.5% price change compared with +8.3% for USPH. Chemed is the larger company by market cap ($7.11 billion vs $1.43 billion), about 5.0 times the size, while U.S. Physical Therapy is growing revenue faster (+16.3% vs +4.1%).
On valuation, Chemed trades at a lower forward P/E (19.7x vs 28.5x for U.S. Physical Therapy). U.S. Physical Therapy offers the higher dividend yield (1.91% vs 0.46%). Chemed converts more of its revenue into profit, with a net margin of 10.5% versus 5.1%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CHE | USPH |
|---|---|---|
| Share price | $548.59 | $95.93 |
| Market cap | $7.11B | $1.43B |
| 1-day change | -0.50% | +1.71% |
| YTD return | +28.22% | +22.85% |
| 1-year return | +24.19% | +33.92% |
| 5-year return | +13.50% | +8.32% |
| P/E ratio (TTM) | 26.27 | — |
| Forward P/E | 19.70 | 28.50 |
| EPS (TTM) | $20.88 | $-1.33 |
| Dividend yield | 0.46% | 1.91% |
| Annual dividend | $2.50 | $1.83 |
| Revenue (latest FY) | $2.53B | $780.99M |
| Revenue growth (YoY) | +4.06% | +16.33% |
| Net income (latest FY) | $265.24M | $39.58M |
| Gross margin | 32.54% | 19.17% |
| Operating margin | 13.37% | 11.10% |
| Net margin | 10.48% | 5.07% |
| 52-week high | $562.24 | $101.80 |
| 52-week low | $365.21 | $58.19 |
| Distance from 52-week high | -2.43% | -5.77% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +12.47% | +16.23% |
| Average volume | 154.97K | 186.22K |
| Shares outstanding | 12.96M | 14.93M |
| Employees | 15,811 | 4,653 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Chemed is about 5.0 times larger than U.S. Physical Therapy by market value ($7.11B vs $1.43B).
- U.S. Physical Therapy offers a meaningfully higher dividend yield (1.91% vs 0.46%).
- Chemed is more profitable, keeping 10.5 cents of every revenue dollar as net income versus 5.1 cents for U.S. Physical Therapy.
- U.S. Physical Therapy grew revenue faster in its latest fiscal year (+16.33% vs +4.06%).
About Chemed
CHE stock →Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, doctors, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates through two segments: VITAS and Roto-Rooter segments.
Health Care · Medical/Nursing Services · 15,811 employees
About U.S. Physical Therapy
USPH stock →U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics.
Health Care · Medical/Nursing Services · 4,653 employees
CHE vs USPH FAQ
Which is bigger, Chemed or U.S. Physical Therapy?
Chemed (CHE) is larger, with a market capitalization of $7.11B compared with $1.43B for U.S. Physical Therapy (USPH).
Which stock has performed better over the past year, CHE or USPH?
USPH returned +33.92% over the past 12 months, compared with +24.19% for CHE (price return, excluding dividends). Past performance does not predict future results.
Which pays a higher dividend, Chemed or U.S. Physical Therapy?
U.S. Physical Therapy has the higher yield at 1.91%, compared with 0.46% for Chemed.
Are Chemed and U.S. Physical Therapy in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.